Focused PCR screen reveals p53 dependence of nitric oxide-induced apoptosis and up-regulation of maspin and plasminogen activator inhibitor-1 in tumor cells

Mol Cancer Res. 2009 Jan;7(1):55-66. doi: 10.1158/1541-7786.MCR-08-0331.

Abstract

We investigated p53-dependent gene expression in nitric oxide (NO)-induced apoptosis of two tumor cell types. Seventy-seven putative p53-regulated genes were screened for NO-mediated expression changes. Twenty-four genes were up-regulated and three genes were down-regulated significantly by NO in human neuroblastoma cells. Genes known to be involved in apoptosis, which were up-regulated by > or = 2-fold, included FAS, CASP-1, BIK, PUMA, DR4 and the serpins maspin (SERPINB5), and plasminogen activator inhibitor-1 (PAI-1). Real-time PCR confirmed maspin and PAI-1 mRNAs exhibited the greatest NO-induced induction, which occurred in a p53-dependent manner. The substantial NO-mediated up-regulation of these serpins mRNAs correlated with large increases in their protein levels, which occurred before or coinciding with apoptosis. p53-deficient neuroblastoma cells were largely resistant to NO killing and showed much reduced maspin and PAI-1 mRNA and protein levels after NO treatment. p53 was activated by NO mainly in the nuclei of neuroblastoma cells. p53(-/-) HCT116 colon carcinoma cells were strongly resistant to NO-induced apoptosis and failed to up-regulate maspin and PAI-1 (in contrast to p53(+/+) HCT116 cells). Our results suggest that both apoptosis and induction of the two serpins by NO require the transcriptional activity of p53. Because maspin is a tumor suppressor and PAI-1 can promote senescence and regulate cell death, it will now be worth investigating whether their p53-mediated expression contributes to the NO-induced p53-dependent death of tumor cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Apoptosis / drug effects*
  • Cell Nucleus / pathology
  • Down-Regulation
  • Gene Expression Regulation, Neoplastic
  • HCT116 Cells / drug effects
  • HCT116 Cells / pathology
  • Humans
  • Neuroblastoma / genetics*
  • Neuroblastoma / pathology
  • Nitric Oxide / pharmacology*
  • Plasmids
  • Plasminogen Activator Inhibitor 1 / genetics*
  • Polymerase Chain Reaction*
  • Reverse Transcriptase Polymerase Chain Reaction
  • Serpins / genetics*
  • Transfection
  • Triazenes / pharmacology
  • Tumor Suppressor Protein p53 / genetics*
  • Up-Regulation

Substances

  • 1-hydroxy-2-oxo-3,3-bis(2-aminoethyl)-1-triazene
  • Plasminogen Activator Inhibitor 1
  • SERPIN-B5
  • SERPINE1 protein, human
  • Serpins
  • TP53 protein, human
  • Triazenes
  • Tumor Suppressor Protein p53
  • Nitric Oxide